Filing Flows › Iridex (IRIX) › R&D spending
Iridex (IRIX) R&D spending by quarter
Iridex's R&D spending was $936K in Q2 2026 (second quarter 2026), +3% from Q1 2026. Over the last 7 quarters it ranged from $871K (Q2 2025) to $1.1M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $936K | +3% | +7% |
| Q1 2026 | $905K | -5% | +3% |
| Q4 2025 | $949K | -2% | -15% |
| Q3 2025 | $972K | +12% | — |
| Q2 2025 | $871K | -0.6% | — |
| Q1 2025 | $876K | -21% | — |
| Q4 2024 | $1.1M | — | — |
Q2 2026 at a glance
Iridex, Q2 2026: revenue $12.6M (-7% year over year), operating margin -8.2%, net loss $1.3M, operating cash flow $174K. The chart follows the revenue to costs, profit and cash.
Questions
What is Iridex's R&D spending?
Iridex's R&D spending was $936K in Q2 2026 (second quarter 2026), +3% from Q1 2026.
How has Iridex's R&D spending changed?
Over the last 7 quarters it ranged from $871K (Q2 2025) to $1.1M (Q4 2024).